ArticleThe Lancet. Oncology2022

Cabozantinib plus atezolizumab in advanced hepatocellular carcinoma and the role of adjuvant antiviral therapy.

Fanpu Ji et al.PubMed ↗Publisher ↗

No numbers read from the abstract.